edCap Advisors funds promising start-up medical technology endeavors through its venture capital arm, GreyMatter Health Ventures. Working with universities, hospitals, scientists, and clinicians, our team provides the resources for new concepts to become quality commercial medical products.
Our primary focus is on pre-seed stage ideas that have the skeleton of a promising medical device, implant, or therapy. We join human, financial, and intellectual capital in an environment that best supports the interests of our institutional partners.
1. Define market opportunity. Our concentration on global healthcare enables us to quickly identify unmet clinical needs in the marketplace, helping to determine the viability of a concept. This leads us to categorize ideas as a “product” or a “company”: Some concepts are best developed for commercialization by a major strategic partner, while others require complete infrastructure necessary for a growing company. Identifying the best strategy early helps us to build an attractive exit.
2. Evaluate value drivers. We examine the intellectual property portfolio, enhancing strategy if necessary, and later evaluate clinical data, the regulatory process, and reimbursement. The combination of these factors creates a clear picture of whether an opportunity is viable and how much of GreyMatter’s time, capital, and human resources are in order to bring it to reality.
3. Seed stage funding. We begin the start-up phase. The team, advisory boards, engineers, scientists, and business leaders are brought together to develop and execute the business plan.
Interested in venture funding for your next big idea?
Contact us at firstname.lastname@example.org